ABP AMERICANBIOETHICS PROJECT

When chronic hemodialysis became available in Seattle, the capacity to provide treatment remained extremely limited.

Medical screening could determine which patients were clinically eligible. It could not determine which eligible patients should receive the available places.

A lay committee therefore participated in selection.

After journalist Shana Alexander described the process in Life magazine in 1962, the committee became associated with the memorable nickname “God Committee.”

Its deliberations became ethically controversial because factors extended beyond medical prognosis. Family responsibilities, occupation, education, income, and perceived contributions to the community could enter consideration.

The problem was not merely that the committee had to choose.

Scarcity sometimes makes selection unavoidable.

The problem was what counted as a reason for choosing one person over another.

Criteria of “social worth” can reproduce existing inequality because people already granted greater opportunities by society may appear more socially valuable precisely because they have received those opportunities.

Allocation systems increasingly attempted to move away from explicit judgments of social worth and toward medical criteria.

Urgency matters. Likelihood of treatment success matters. Contraindications matter. Expected benefit may matter.

This represented an important ethical development.

But medical criteria do not eliminate moral judgment.

Imagine two patients competing for one resource. One is more likely to die without it. The other is more likely to survive if treated.

Should priority go to the sickest patient or to the patient most likely to benefit?

Clinical evidence can estimate prognosis.

It cannot, by itself, tell us which outcome justice should prioritize.

Organ transplantation transformed scarcity from an exceptional crisis into a permanent institutional problem.

There will ordinarily be fewer transplantable organs than people who could benefit from receiving them.

Allocation systems therefore use combinations of criteria such as medical urgency, biological compatibility, waiting time, geography, and likelihood of benefit.

The ethical achievement is not the discovery of a perfect formula.

It is the effort to replace informal judgments about personal worth with criteria that can be stated, scrutinized, revised, and publicly defended.

Even then, apparently medical factors can carry social histories inside them.

Medication adherence may affect transplant outcomes. So may stable housing, transportation, mental health, substance-use disorder, caregiving support, and the ability to attend repeated appointments.

If social disadvantage makes adherence more difficult, using adherence as a purely neutral criterion can reproduce disadvantage while appearing entirely medical.

Disability creates a particularly important allocation problem.

If resources are distributed according to expected quality of life, disabled people may be disadvantaged by assumptions that life with disability is inherently worse.

Yet prognosis can be clinically relevant. So can the burdens and benefits of treatment.

The crucial distinction is between evaluating what the treatment can accomplish and evaluating whether the person receiving the treatment has a life worth preserving.

Those are not the same judgment.

Allocation systems need ways to consider clinically relevant differences without allowing disability to become a proxy for diminished human worth.

Scarcity is not limited to dramatic decisions involving organs or ventilators.

American healthcare distributes access through employment, private insurance, public programs, personal wealth, institutional charity, and government policy.

The creation of Medicare and Medicaid in 1965 expanded access to healthcare for millions of Americans while leaving broader questions about coverage unresolved.

Bioethics can therefore distinguish microallocation from macroallocation.

Microallocation asks which patient receives a particular scarce resource.

Macroallocation asks how society distributes healthcare resources across populations: which services are covered, which institutions are funded, where hospitals are located, who qualifies for public programs, and how much of society's resources should be devoted to healthcare.

The ethical stakes are less visible than a bedside decision.

They may be much larger.

One influential position begins from healthcare's special importance to human functioning and opportunity.

Illness can restrict a person's ability to participate in education, work, family, civic life, and nearly every other sphere. On this account, access to an adequate level of healthcare belongs among the conditions a just society should secure.

Other approaches emphasize that healthcare is only one social good among many.

Money devoted to medical treatment cannot simultaneously be spent on housing, education, food security, environmental protection, or public safety—all of which can affect health.

Calling healthcare a right therefore does not end the allocation debate.

It creates additional questions.

How much healthcare does the right require? Which services count? Who owes the obligation? How should it be financed? Are there limits to what a society must provide when increasingly expensive interventions produce increasingly small benefits?

The difficult ethical work lies in specifying the content and boundaries of the claim.

Health systems often attempt to compare the benefits produced by different interventions.

Cost-effectiveness analysis and measures such as quality-adjusted life years (QALYs) make some of these comparisons possible.

Such tools can reveal opportunity costs that would otherwise remain hidden. Money spent on one intervention cannot be spent twice.

But measurement introduces its own moral assumptions.

Whose assessment determines the quality assigned to a particular health state? Could a system systematically undervalue additional years of life for people living with disabilities because those years receive a lower numerical weight?

Quantification can clarify tradeoffs.

Numbers do not make the moral assumptions behind the comparison disappear.

Scarcity creates a recurring temptation to distinguish between patients considered responsible for their illnesses and those considered innocent.

Should smoking affect priority for treatment? Alcohol use? Obesity? Failure to take medication? Participation in dangerous activities?

The intuition is understandable when resources are scarce.

Yet behavior develops within complicated networks of genetics, addiction, education, poverty, trauma, environment, culture, commercial influence, and access to preventive care.

Medicine also routinely treats people after risky behavior without first determining whether they deserve rescue.

Behavior may sometimes be medically relevant because it predicts whether treatment is likely to succeed.

That is different from deciding whether a person deserves to be saved.

The COVID-19 pandemic made allocation newly visible.

Hospitals prepared for possible shortages of ventilators, intensive-care beds, medications, protective equipment, and healthcare personnel.

Crisis standards of care attempted to replace improvised bedside decisions with predetermined allocation frameworks.

Longstanding controversies immediately returned.

Should systems maximize lives saved? Should expected life-years matter? Should healthcare workers receive priority? Could age be considered? Would prognosis scores disadvantage disabled patients? When does a medical exclusion become discrimination?

The pandemic did not create these questions.

It compressed them into decisions that could no longer remain theoretical.

Appeals to equality do not by themselves tell us how to allocate scarce resources.

A lottery gives eligible patients equal chances.

First-come, first-served applies the same temporal rule to everyone.

Prioritizing the sickest gives special weight to urgency.

Maximizing survival treats each successfully saved life as equally valuable.

These rules can select different patients while each appeals to a recognizable form of fairness.

The task is therefore not simply to declare that people are equal.

It is to explain what should be equalized and why.

Scarcity changes the structure of clinical ethics because it introduces another patient whose claim may be equally serious.

Respecting one patient's autonomy cannot create an additional organ. Beneficence toward one patient may conflict with beneficence toward another. Maximizing successful outcomes can disadvantage people with worse prognoses. Prioritizing the sickest can use resources where success is least likely. Lotteries avoid some judgments while deliberately ignoring differences that may matter.

No allocation principle eliminates loss.

That is why allocation ethics ultimately concerns institutions as much as individual decisions.

A defensible system must be capable of explaining why morally relevant differences count, why irrelevant differences do not, and why the rules governing scarce and sometimes life-saving resources should remain open to public scrutiny.

1. 1960

   Chronic hemodialysis becomes technically possible

2. 1962

   Seattle dialysis allocation becomes national news

3. 1965

   Medicare and Medicaid established

4. 1984

   National Organ Transplant Act

5. 1980s–1990s

   Cost-effectiveness and priority-setting debates expand

6. 1990

   Americans with Disabilities Act

7. 2010

   Affordable Care Act

8. 2020

   COVID-19 pandemic